NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-64 Cr |
| Mar2024 | ₹-121 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-36 Cr |
| Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-64 Cr | Negative | |
| Mar2024 | ₹-121 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-36 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,052.2 Cr | 0.8% | 5.7% | -4.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹285,903.0 Cr | -0.7% | 2.5% | -0.3% | Stock Analytics | |
| REDINGTON | ₹20,732.7 Cr | -1.3% | -2.8% | 17.7% | Stock Analytics | |
| MMTC | ₹9,829.5 Cr | 2.4% | 3% | -2.2% | Stock Analytics | |
| HONASA CONSUMER | ₹9,730.2 Cr | 4.9% | 3.1% | 33.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,770.0 Cr | -4.1% | -4.1% | 20.7% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 0.8% |
5.7% |
-4.4% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses